CT-388
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Roche · Phase 3 · Recruiting · Enrollment 300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Enicepatide Dose 1 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Enicepatide Dose 2 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Enicepatide Dose 3 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |